高聚生在肿瘤临床治疗中应用.pdfVIP

2008骞寸35鍗风16鏈 涓浗鑲跨槫涓村簥 路953路 楂樿仛鐢熷湪鑲跨槫涓村簥娌荤枟涓殑搴旂敤 鈶 鈶 鈶 闃 鏄 闄 鍐 璧垫枃鍗 閮 宸 缁艰堪 鍒樻槍瀛 瀹＄ 澶╂触鍖荤澶у鑲跨槫鍖婚櫌鍥藉鑽搧涓村簥璇曢獙鍩哄湴 锛堝ぉ娲ュ競 300060锛 鎽樿 鏈枃鎬荤粨浜嗚繎100绡囧彂琛ㄧ殑鐮旂┒璁烘枃锛岃堪璇勪簡楂樿仛鐢熷湪鑲跨槫涓村簥娌荤枟涓殑搴旂敤鎯呭喌銆傞珮鑱氱敓灞炴潵婧愪簬 閲戦粍鑹茶憽钀勭悆鑿屼唬璋骇鐗╀腑鐨勮秴鎶楀師銆傜爺绌惰涓哄叿鏈夋姂鍒跺拰鏉€浼よ偪鐦わ紝鑳芥槑鏄剧殑淇缁勭粐鍜岀粏鑳烇紝鍗囬珮鐧界粏鑳烇紝鎻 楂樺厤鐤姛鑳界瓑鍔熸晥銆傚叾鍏嶇柅瀛︿綔鐢ㄥ湪浜庢椿鍖朤缁嗚優銆佽嚜鐒舵潃浼ょ粏鑳烇紝澧炲己鍚炲櫖缁嗚優鐨勫悶鍣綔鐢ㄥ拰娣嬪反缁嗚優鏉€浼ゆ椿 鍔涳紝骞惰兘鍗囬珮澶栧懆琛€涓殑鐧界粏鑳烇紝淇鎹熶激鐨勭粍缁囩粏鑳烇紝杩樿兘鐩存帴鎶戝埗鑲跨槫缁嗚優鐨勭敓闀裤€傚畠鍦ㄨ偪鐦や复搴婃不鐤椾腑寰楀埌 骞挎硾搴旂敤锛屽崟鐙厰鍐呯亴娉ㄥ叿鏈夋秷闄ゆ伓鎬ц兏鑵规按鐨勬樉钁椾綔鐢紝涓庡寲鐤楄嵂鐗╁悓鏃剁亴娉紝澶уぇ鎻愰珮鑳歌吂姘存秷闄ょ巼銆傚畠鑳芥彁 楂樻斁銆佸寲鐤楃枟鏁堬紝澶уぇ鎻愰珮鍗曠嫭鍖栫枟鍜屾斁鐤楃殑鏈夋晥鐜囥€備篃鑳芥彁楂樻偅鑰呯殑鍏嶇柅鍔熻兘锛屽噺杞诲洜鏀俱€佸寲鐤楀紩璧风殑鑳冭偁閬撳弽 搴斻€傚洜姝ゅ叾涓昏閫傚簲鐥囦负鎭舵€ц偪鐦わ紝鐧界粏鑳炲噺灏戯紝鎭舵€ц兏鑵规按锛屼互鍙婂叿鏈夐檷浣庢斁鍖栫枟寮曡捣鐨勫壇鍙嶅簲鍜屾敼鍠勫厤鐤姛鑳 鐨勪綔鐢ㄣ€ 鍏抽敭璇 楂樿仛鐢 鍏嶇柅鍔熻兘 鑲跨槫娌荤枟 鑱斿悎鐢ㄨ嵂銆 Clinical Application of Highly Agglutinative Staphylococcin in Cancer Treatment 1 2 1 1 3 YAN Zhao , CHEN Jun , ZAHO Wenhua , GUO Wei , LIU Changxiao Corresponding author: LIU Changxiao, E-mail: liuchangxiao@ 1Clinical Trial Base for New Drug Evaluation Research, Cancer Institute Hospital of Tianjin Medical Uinversity, Tianjin 300060, China 2Shenyang Xiehe Biopharmaceutical Co Ltd. Shenyang, 110179, China 3 Research Center of New Drug Evaluation, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, Chi- na HAS is a superantigen extracted from staphylococcus aureus metabolite. Studies have shown that through activating T cells and natural killer cells, enhancing phagocytes phagocytosis and killing ability of lym- phocytes, increasing leucocyte count in peripheral blood, and repairing impaired histiocytes, HAS can im- prove the immune fun